Rallybio CorporationRLYBNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | -83.33% | +0.00% | -29.10% | -29.10% |
| Gross Profit Growth | +0.00% | -92.98% | +0.00% | -20.00% | -29.10% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +10.02% | +9.89% | +9.81% | +1.62% | +1.04% |
| Weighted Average Shares Diluted Growth | +10.02% | +9.89% | +9.81% | +1.62% | +1.04% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -40.68% | -41.09% | -41.64% | -44.82% | -14.36% |
| Book Value per Share Growth | -47.91% | -47.16% | -44.77% | -43.47% | -11.91% |
| Debt Growth | -46.26% | -60.71% | -65.78% | -79.58% | -13.91% |
| R&D Expense Growth | -37.99% | -53.81% | -55.62% | -52.96% | -49.72% |
| SG&A Expenses Growth | -32.10% | -17.87% | -39.32% | -4.40% | -27.42% |